Gerresheimer names new Chairman of the Supervisory Board Gerresheimer names new Chairman of the Supervisory Board This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy Hovione appoints Stefan Doboczky as Chief Executive Officer Hovione appoints Stefan Doboczky as Chief Executive Officer Chairman of the board of directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027 Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience Specialist pharmaceutical experience strengthens Symbiosis’ international growth ambitions Virginie Cavalli appointed Chief Executive Officer of Seppic Virginie Cavalli appointed Chief Executive Officer of Seppic Seppic announces the appointment of Virginie Cavalli as Chief Executive Officer, effective September 1, 2026 Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG Wolf Lehmann, CFO, and Achim Schalk, Member of the Management Board, will assume his duties until further notice Symbiosis strengthens commercial team with appointment of Jay Chima Symbiosis strengthens commercial team with appointment of Jay Chima Symbiosis appoints Jay Chima as vice president, business development, to support growth and strengthen partnerships across the pharmaceutical and biotechnology sectors Lonza appoints Samanta Cimitan as chief commercial officer Lonza appoints Samanta Cimitan as chief commercial officer Newly created role will strengthen customer engagement, commercial delivery and a harmonised go-to-market approach across One Lonza Piramal Pharma completes acquisition of controlling stake in Yapan Bio Piramal Pharma completes acquisition of controlling stake in Yapan Bio Acquisition strengthens Piramal’s biologics capabilities and integrated large molecule CDMO offering Anders Fogelberg appointed president and CEO of BICO Group AB Anders Fogelberg appointed president and CEO of BICO Group AB BICO appoints current Chief Commercial Officer Anders Fogelberg as President and CEO, effective September 1, 2026 Pace appoints Andy Fenny as President of Pace Life Sciences Pace appoints Andy Fenny as President of Pace Life Sciences Experienced life sciences executive brings more than 20 years of CDMO and pharmaceutical leadership to drive strategic growth Clinilabs announces leadership expansion Clinilabs announces leadership expansion Laura Shannon joins the organisation as Chief Executive Officer while Gary Zammit, the Company’s founder, assumes the role of Executive Chairperson As new CTO, Christian Reichardt is driving the technological advancement of Optima Pharma As new CTO, Christian Reichardt is driving the technological advancement of Optima Pharma This investment is driven by growth areas such as biologics, GLP-1 products, and other sterile pharmaceuticals, as well as the increasing demand for isolator and high-potency... Reacta Healthcare appoints Iedena Lima as head of research and development Reacta Healthcare appoints Iedena Lima as head of research and development Extensive pharma and medtech sector experience strengthens senior leadership to support growth and strategic expansion Clinilabs announces medical leadership appointments Clinilabs announces medical leadership appointments Bob Dagher, M.D., named chief medical officer and Waqar Ahmed Siddiqui, M.D., named principal investigator